Global Brucellosis Market, By Treatment (Medication, Others), Transmission (Raw Dairy Products, Inhaling Contaminated Air, Infected Blood & Body Fluids, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy) – Industry Trends and Forecast to 2029.
Brucellosis Market Analysis and Size
The brucellosis market is expected to witness significant growth during the forecast period. Emerging markets and huge investment in research and development are the factors responsible for the growth of this market. The growth of global uveitis market enhanced by the growing cases of glaucoma and rise in research and development activities conducted by many pharmaceuticals’ companies. COVID-19 also had a major impact on the market growth.
Data Bridge Market Research analyses a growth rate in the brucellosis market in the forecast period 2022-2029. The expected CAGR of global brucellosis market is tend to be around 4.50% in the mentioned forecast period. The market was valued at USD 253.14 million in 2021, and it would grow upto 359.9 million by 2029. In addition to the market insights such as market value, growth rate, market segments, geographical coverage, market players, and market scenario, the market report curated by the Data Bridge Market Research team also includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Brucellosis is the bacterial infection spread from animals to humans through direct contact with blood or body fluid of infected animals, eating raw dairy products and inhaling contaminated air. The symptoms of brucellosis include fever, chills, loss of appetite, weakness, fatigue, joint and muscle pain.
Brucellosis Market Scope and Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2014 - 2019)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
By Treatment (Medication, Others), Transmission (Raw Dairy Products, Inhaling Contaminated Air, Infected Blood & Body Fluids, Others), Route of Administration (Oral, Parenteral, Others), End-Users (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America
|
|
Market Players Covered
|
Fresenius SE & Co. KGaA (Germany), Pfizer Inc (U.S.), Mylan N.V. (U.S.), Novartis AG (Switzerland), Hikma Pharmaceuticals plc (U.K.), Aurobindo Pharma (India), AbbVie Inc. (Ireland), Melinta Therapeutics, Inc (U.S.), Bayer AG (Germany), Colorado Serum Company (U.S.), Indian Immunologicals Ltd. (India), Hester Biosciences Limited (India), Jordan Bio-industries Center (Jordan), Tornel Laboratories (Mexico)
|
|
Market Opportunities
|
|
Global Brucellosis Market Dynamics
Drivers
- Increased Acquisitions and Collaboration
The rising adoption of strategies such as acquisitions & agreement by major market players is expected to boost the market growth over the forecast period. For instance, Hester Biosciences Limited finalized an agreement with IVRI (Indian Veterinary Research Institute) to acquire Brucella vaccine technology for the development of the Brucella Abortus S19 Delta Pevaccine from IVRI Hester. This boost the market growth.
- Rising Demand for Oral Drugs
Oral drugs is expected to boost the market growth. The segment is expected to accelerate the global market as most products are available in capsule and tablet form and it is a very feasible route of administration.
Opportunities
- Rising Investment By Major Market Players
All the market players are making huge investments in increasing the market growth. For instance, Biovet Private Ltd which is an animal health vaccine producing company located in Karnataka, India, declared in August 2019 that it will invest US$ 26,212,600 for the expansion of foot & mouth and brucellosis vaccine manufacturing facilities in Malur, Karnataka, India. This is expected to drive market growth over the forecast period
- Increasing Demand for Retail Pharmacies
Rise in the number of open angle glaucoma therapeutics being delivered through retail pharmacies and surge in the number of retail pharmacies in developed countries create opportunities for the market growth. In addition to this, patients prefer retail pharmacies for purchasing drugs, as these are easily accessible.
Restraints/Challenges
- Complications Associated With Brucellosis Vaccines
Severe complications associated with the use of this kind of vaccines could curb the growth of the global brucellosis market over a forecast period. According to the journal Veterinary Research, complications such as pathogenicity for humans, diagnostic tests and potential to cause abortion in pregnant animals, among others are restraining the market growth.
- High Cost
The huge expenditure associated with uveitis medications surely hamper the market growth.
This global uveitis market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on the global uveitis market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
COVID-19 Impact on Global Brucellosis Market
Considering the pandemic scenario, stakeholders in the brucellosis market are reanalyzing financial assistance programs linked with COVID-19 appropriations for eligibility. There are restricted budgets that are associated with the market.
In the post-pandemic era, the biotechnology and pharmaceutical industries are expected to witness a huge growth in the future, due to the demand for vaccine and treatment drugs for COVID-19. Thus, this will leave a significant impact on the brucellosis market.
Global Brucellosis Market Scope
The global brucellosis market is segmented on the basis of treatment, transmission, route of administration, distribution channel and end-user. The growth amongst these segments will help you analyze meagre growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Treatment
- Medication
- Others
Transmission
- Raw Dairy Products
- Inhaling Contaminated Air
- Infected Blood & Body Fluids
- Others
Route Of Administration
- Oral
- Parenteral
- Others
End User
- Hospitals
- Homecare
- Specialty Clinics
- Others
Distribution Channel
- Hospital Pharmacy
- Online Pharmacy
- Retail Pharmacy
Brucellosis Market Regional Analysis/Insights
The brucellosis market is analysed and market size insights and trends are provided by treatment, transmission, route of administration, distribution channel and end-user as referenced above.
The major countries covered in the brucellosis market report are the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
Europe has been witnessing a positive growth for global brucellosis market throughout the forecasted period due to growing animal husbandry, poultry and presence of generic manufacturers.
North America dominates the market due presence of new advanced technology, and high R&D & healthcare expenditure.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Competitive Landscape and Global Brucellosis Market Share Analysis
The brucellosis market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to brucellosis market
Key players operating in the brucellosis market include:
- Fresenius SE & Co. KGaA (Germany)
- Pfizer Inc (U.S.)
- Mylan N.V. (U.S.)
- Novartis AG (Switzerland)
- Hikma Pharmaceuticals plc (U.K.)
- Aurobindo Pharma (India)
- AbbVie Inc. (Ireland)
- Melinta Therapeutics, Inc (U.S.)
- Bayer AG (Germany)
- Colorado Serum Company (U.S.)
- Indian Immunologicals Ltd. (India)
- Hester Biosciences Limited (India)
- Jordan Bio-industries Center (Jordan)
- Tornel Laboratories (Mexico)
SKU-